Renal and splanchnic exchange of human biosynthetic C-peptide in Type 1 (insulin-dependent) diabetes mellitus

[1]  A. Lefvert,et al.  Residual insulin production, glycaemic control and prevalence of microvascular lesions and polyneuropathy in long-term Type 1 (insulin-dependent) diabetes mellitus , 1987, Diabetologia.

[2]  Z. Zadik,et al.  Correlation of Urinary Excretion of C-Peptide with the Integrated Concentration and Secretion Rate of Insulin , 1981, Diabetes.

[3]  K. Polonsky,et al.  Metabolism of C-peptide in the dog. In vivo demonstration of the absence of hepatic extraction. , 1983, The Journal of clinical investigation.

[4]  M. Rendell,et al.  Estimation of the Secretion Rate of Insulin from the Urinary Excretion Rate of C-Peptide: Study in Obese and Diabetic Subjects , 1982, Diabetes.

[5]  E. Pfeiffer,et al.  Effects of synthetic rat C-peptide in normal and diabetic rats , 1983, Diabetologia.

[6]  D. Steiner,et al.  The metabolism of proinsulin and insulin by the liver. , 1972, The Journal of clinical investigation.

[7]  D L Horwitz,et al.  Determination of Free and Total Insulin and C-Peptide in Insulin-treated Diabetics , 1977, Diabetes.

[8]  J. Bülow,et al.  Kinetics of circulating endogenous insulin, C-peptide, and proinsulin in fasting nondiabetic man. , 1987, Metabolism: clinical and experimental.

[9]  L. Heding.  Radioimmunological determination of human C-peptide in serum , 1975, Diabetologia.

[10]  J. Juang,et al.  C-peptide response to glucagon in young diabetics. , 1989, Taiwan yi xue hui za zhi. Journal of the Formosan Medical Association.

[11]  H. W. Smith,et al.  THE RENAL CLEARANCES OF SUBSTITUTED HIPPURIC ACID DERIVATIVES AND OTHER AROMATIC ACIDS IN DOG AND MAN. , 1945, The Journal of clinical investigation.

[12]  L. Regeur,et al.  Plasma C-peptide in uraemic patients. , 1978, Scandinavian journal of clinical and laboratory investigation.

[13]  T. Kita,et al.  [An estimation of plasma catecholamines by high performance liquid chromatography with electrochemical detection (author's transl)]. , 1981, Nihon Naibunpi Gakkai zasshi.

[14]  A. Katz,et al.  Quantitation of Human Pancreatic Beta-cell Function by Immunoassay of C-Peptide in Urine , 1977, Diabetes.

[15]  R. Rabkin,et al.  The Handling of Insulin, Proinsulin, and C-peptide by the Isolated Rat Kidney , 1978, Diabetes.

[16]  A. Kitabchi.  The biological and immunological properties of pork and beef insulin, proinsulin, and connecting peptides. , 1970, The Journal of clinical investigation.

[17]  K. Polonsky,et al.  Ingestion of a mixed meal does not affect the metabolic clearance rate of biosynthetic human C-peptide. , 1986, The Journal of clinical endocrinology and metabolism.

[18]  L. Rowell,et al.  INDOCYANINE GREEN CLEARANCE AND ESTIMATED HEPATIC BLOOD FLOW DURING MILD TO MAXIMAL EXERCISE IN UPRIGHT MAN. , 1964, The Journal of clinical investigation.

[19]  C. Mogensen,et al.  Increased Kidney Size and Glomerular Filtration Rate in Early Juvenile Diabetes , 1973, Diabetes.

[20]  Bruce H. Frank,et al.  Use of biosynthetic human C-peptide in the measurement of insulin secretion rates in normal volunteers and type I diabetic patients. , 1986, The Journal of clinical investigation.

[21]  P. Foà,et al.  Insulin Secretion and Glucose Uptake by Isolated Islets of the Hamster Effect of Insulin, Proinsulin and C-Peptide* , 1976, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[22]  R. Eaton,et al.  Hepatic removal of insulin in normal man: dose response to endogenous insulin secretion. , 1983, The Journal of clinical endocrinology and metabolism.

[23]  E. Bonora,et al.  Renal metabolism of C-peptide in man. , 1987, The Journal of clinical endocrinology and metabolism.

[24]  B. Hoogwerf,et al.  Infusion of synthetic human C-peptide does not affect plasma glucose, serum insulin, or plasma glucagon in healthy subjects. , 1986, Metabolism: clinical and experimental.

[25]  L. Hagenfeldt,et al.  A gas chromatographic method for the determination of individual free fatty acids in plasma. , 1966, Clinica chimica acta; international journal of clinical chemistry.

[26]  H. Arnqvist,et al.  Free and total insulin as determined after precipitation with polyethylene glycol: analytical characteristics and effects of sample handling and storage. , 1987, Clinical chemistry.

[27]  S. Genuth.  Plasma insulin and glucose profiles in normal, obese, and diabetic persons. , 1973, Annals of internal medicine.

[28]  M. Knip,et al.  Clinical Significance of Urinary C‐Peptide Excretion in Children with Insulin‐Dependent Diabetes Mellitus , 1989, Acta paediatrica Scandinavica.

[29]  R. DeFronzo,et al.  Glucose clamp technique: a method for quantifying insulin secretion and resistance. , 1979, The American journal of physiology.

[30]  P. Hjemdahl,et al.  Determination of plasma catecholamines by high performance liquid chromatography with electrochemical detection: comparison with a radioenzymatic method. , 1979, Life sciences.

[31]  H. Ranney,et al.  Hemoglobin components in patients with diabetes mellitus. , 1971, The New England journal of medicine.

[32]  D L Horwitz,et al.  Kinetics of human connecting peptide in normal and diabetic subjects. , 1978, The Journal of clinical investigation.